HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 72 filers reported holding HARVARD BIOSCIENCE INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $424,642 | -42.6% | 98,754 | -26.7% | 0.00% | -66.7% |
| Q2 2023 | $739,228 | +183.2% | 134,650 | +116.6% | 0.00% | +200.0% |
| Q1 2023 | $261,034 | +358.0% | 62,151 | +177.7% | 0.00% | – |
| Q3 2022 | $57,000 | -64.4% | 22,377 | -49.8% | 0.00% | -100.0% |
| Q2 2022 | $160,000 | -15.8% | 44,582 | +45.4% | 0.00% | 0.0% |
| Q1 2022 | $190,000 | -78.6% | 30,653 | -75.6% | 0.00% | -66.7% |
| Q4 2021 | $886,000 | +129.5% | 125,640 | +127.0% | 0.00% | +200.0% |
| Q3 2021 | $386,000 | -46.8% | 55,356 | -76.3% | 0.00% | -80.0% |
| Q2 2020 | $725,000 | -46.5% | 234,000 | -46.9% | 0.01% | -44.4% |
| Q3 2019 | $1,354,000 | +5107.7% | 440,346 | +3295.9% | 0.01% | – |
| Q2 2019 | $26,000 | -92.7% | 12,967 | -84.3% | 0.00% | -100.0% |
| Q1 2019 | $357,000 | – | 82,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |